267 related articles for article (PubMed ID: 28834447)
21. Background parenchymal enhancement and fibroglandular tissue on breast MRI in women with high genetic risk: Are changes before and after risk-reducing salpingo-oophorectomy associated with breast cancer risk?
Bermot C; Saint-Martin C; Malhaire C; Sebbag-Sfez D; Mouret-Fourme E; Carton M; Thibault FE
Eur J Radiol; 2018 Dec; 109():171-177. PubMed ID: 30527300
[TBL] [Abstract][Full Text] [Related]
22. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
23. Positive predictive value of BI-RADS MR imaging.
Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
[TBL] [Abstract][Full Text] [Related]
24. PPV of the Molecular Breast Imaging Lexicon.
Hunt KN; Conners AL; Samreen N; Rhodes DJ; Johnson MP; Hruska CB
AJR Am J Roentgenol; 2023 Jan; 220(1):40-48. PubMed ID: 35856455
[No Abstract] [Full Text] [Related]
25. Identification of Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Breast Cancer: A Retrospective Study.
Kang JH; Youk JH; Kim JA; Gweon HM; Eun NL; Ko KH; Son EJ
Korean J Radiol; 2018; 19(5):897-904. PubMed ID: 30174479
[TBL] [Abstract][Full Text] [Related]
26. Clumped vs non-clumped internal enhancement patterns in linear non-mass enhancement on breast MRI.
Chen ST; Covelli J; Okamoto S; Daniel BL; DeMartini WB; Ikeda DM
Br J Radiol; 2021 Feb; 94(1118):20201166. PubMed ID: 33332980
[TBL] [Abstract][Full Text] [Related]
27. Descriptors of Malignant Non-mass Enhancement of Breast MRI: Their Correlation to the Presence of Invasion.
Machida Y; Shimauchi A; Tozaki M; Kuroki Y; Yoshida T; Fukuma E
Acad Radiol; 2016 Jun; 23(6):687-95. PubMed ID: 26976623
[TBL] [Abstract][Full Text] [Related]
28. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
[TBL] [Abstract][Full Text] [Related]
29. Focal Breast Lesions in Clinical CT Examinations of the Chest: A Retrospective Analysis.
Krug KB; Houbois C; Grinstein O; Borggrefe J; Puesken M; Hanstein B; Malter W; Maintz D; Hellmich M
Rofo; 2017 Oct; 189(10):977-989. PubMed ID: 28683503
[No Abstract] [Full Text] [Related]
30. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
[TBL] [Abstract][Full Text] [Related]
31. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging diagnosis of non-mass enhancement of the breast.
Kubota K; Mori M; Fujioka T; Watanabe K; Ito Y
J Med Ultrason (2001); 2023 Jul; 50(3):361-366. PubMed ID: 36801992
[TBL] [Abstract][Full Text] [Related]
33. Foci on breast magnetic resonance imaging in high-risk women: cancer or not?
Clauser P; Cassano E; De Nicolò A; Rotili A; Bonanni B; Bazzocchi M; Zuiani C
Radiol Med; 2016 Aug; 121(8):611-7. PubMed ID: 27169908
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
35. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement.
Tozaki M; Igarashi T; Fukuda K
AJR Am J Roentgenol; 2006 Aug; 187(2):313-21. PubMed ID: 16861532
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Diagnostic Accuracy and Efficiency of Categories 4 and 5 of the Second Edition of the BI-RADS Ultrasound Lexicon in Diagnosing Breast Lesions.
Zou X; Wang J; Lan X; Lin Q; Han F; Liu L; Li A
Ultrasound Med Biol; 2016 Sep; 42(9):2065-71. PubMed ID: 27262521
[TBL] [Abstract][Full Text] [Related]
37. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
[No Abstract] [Full Text] [Related]
38. Use of the probably benign (BI-RADS category 3) assessment for masses on breast MRI: Is it transferable to general clinical practice?
Price ER; Sickles EA; Yitta S; Brasic N; Yeh MJ; Allen IE; Joe BN
Breast J; 2018 Mar; 24(2):109-114. PubMed ID: 28845605
[TBL] [Abstract][Full Text] [Related]
39. A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
Onishi N; Kataoka M; Kanao S; Kawai M; Iima M; Ohashi A; Toi M; Togashi K
Breast Cancer; 2017 Jan; 24(1):69-78. PubMed ID: 26832858
[TBL] [Abstract][Full Text] [Related]
40. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
